What happened: the shortage and its end
When Ozempic demand surged in 2022-2023, Novo Nordisk's manufacturing capacity could not keep up. The FDA placed semaglutide on its drug shortage list, which triggered a specific exemption allowing 503A and 503B compounding pharmacies to produce compounded semaglutide under shortage rules.
The shortage created a massive telehealth boom. Dozens of legitimate physician-supervised programs emerged, along with grey-market vendors selling unlicensed versions. Patients who could not access or afford branded Ozempic or Wegovy found compounded alternatives at $150-400/month.
In late 2024, the FDA concluded Ozempic and Wegovy supply had sufficiently recovered and removed semaglutide from the shortage list. This triggered several enforcement actions:
- 503B outsourcing facilities (large-scale compounders) were told to stop producing compounded semaglutide entirely
- 503A pharmacies (patient-specific compounders) can still produce compounded semaglutide under certain circumstances, specifically for patients with a documented clinical need not met by the branded product
- Enforcement of grey-market vendors selling unlicensed "semaglutide" increased significantly
---
What is still legally available in 2026
Compounded semaglutide from 503A pharmacies remains available, but the landscape has narrowed:
- A valid prescription from a licensed physician is required
- The physician must have a legitimate clinical rationale for compounded vs. branded semaglutide (e.g., the patient cannot tolerate the branded formulation, has an allergy to an excipient, or needs a different dose or delivery method)
- The compounding pharmacy must be properly licensed and operating within 503A rules
Many legitimate telehealth clinics still offer compounded semaglutide through 503A partnerships. The pathway is not closed - it is just more restricted than it was during the shortage.
Branded options with better access:
- Novo Nordisk has significantly expanded production. Ozempic and Wegovy are generally available at pharmacies, though insurance coverage for weight loss (Wegovy) remains inconsistent.
- Tirzepatide (Mounjaro/Zepbound) has filled significant demand. Zepbound's weight loss data are actually superior to Wegovy in head-to-head comparisons. Compare semaglutide vs. tirzepatide.
---
What this means for current patients
If you are currently on compounded semaglutide through a legitimate clinic:
- Your program is likely still intact. Ask your clinic directly whether they are using 503A compounding and what their current pharmacy relationship is.
- Clinics operating properly have adapted their pharmacy sourcing. This is routine for compliant operations.
- If your clinic cannot answer basic questions about where your medication is compounded, that is a red flag.
If you are starting fresh and looking for GLP-1 therapy:
- Telehealth clinics remain the fastest route to evaluation and prescription
- Ask whether you would receive branded or compounded medication, and from which pharmacy
- Compare costs: branded Wegovy with insurance may be cost-competitive with compounded alternatives depending on your plan
- Consider tirzepatide (Zepbound) - it is FDA-approved for weight management and has shown greater weight loss in trials
---
What to ask your clinic
Before starting any GLP-1 program, ask:
- 1Will I receive branded or compounded medication?
- 2If compounded - which 503A pharmacy fills the prescription?
- 3Is that pharmacy accredited (e.g., PCAB accreditation)?
- 4What is the dosing schedule and titration plan?
- 5What monitoring is included and how often will I have follow-up contact?
A clinic that cannot answer questions 1-3 clearly should be viewed with caution.
---
Finding a GLP-1 clinic in 2026
Peptide Finder lists physician-supervised GLP-1 clinics operating within the current regulatory framework:
- Find semaglutide prescribers - telehealth and local options
- Find tirzepatide prescribers - Mounjaro / Zepbound
- Browse weight loss clinics
Browse by state: California - Texas - Florida - New York - Georgia - browse all states.
Frequently asked questions
Is compounded semaglutide still available in 2026?
Yes, but access is more restricted than during the shortage period. 503A compounding pharmacies can still produce compounded semaglutide for patients with a valid prescription and a documented clinical need. Many legitimate telehealth clinics continue to offer it through compliant pharmacy partners.
Why did compounded semaglutide become harder to get?
The FDA declared the semaglutide shortage resolved in late 2024. This ended the blanket shortage-based exemption that had allowed 503B outsourcing facilities to produce compounded semaglutide at scale. 503A pharmacies can still compound for individual patients under specific circumstances.
What is the difference between 503A and 503B compounding pharmacies?
503A pharmacies compound medications for individual named patients with a valid prescription. 503B outsourcing facilities produce larger batches for healthcare providers. 503B facilities lost their ability to compound semaglutide once the shortage ended; 503A pharmacies retained limited compounding rights.
Is branded Wegovy now easier to get than compounded semaglutide?
In many cases, yes. Novo Nordisk expanded manufacturing significantly. Wegovy and Ozempic are more reliably available at pharmacies than during the peak shortage years. Insurance coverage remains inconsistent for weight loss indications.
Should I consider tirzepatide instead of semaglutide?
Tirzepatide (Zepbound for weight loss) has shown greater average weight loss than semaglutide in head-to-head comparisons. It is FDA-approved and widely available. A prescribing physician can advise on which is appropriate given your health history, cost, and goals.
How do I find a legitimate GLP-1 clinic in 2026?
Use Peptide Finder to compare telehealth and in-person clinics by state. Look for a named prescribing physician, a real consultation process, clear pharmacy sourcing, and transparent pricing. Avoid clinics that cannot answer basic questions about where your medication is compounded.
Related: Where to buy peptides legally in the US - Compounded peptides: what to know